Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule. Read more about Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule.
Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil. Read more about Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil.
Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice. Read more about Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice.
Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture. Read more about Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture.
Elevated plasma tamoxifen levels in a patient with liver obstruction. Read more about Elevated plasma tamoxifen levels in a patient with liver obstruction.
Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia. Read more about Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia.
Cytotoxicity of ketoconazole in malignant cell lines. Read more about Cytotoxicity of ketoconazole in malignant cell lines.
Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cells. Read more about Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cells.
Kinetics and sensitivity of daunorubicin in patients with acute leukemia. Read more about Kinetics and sensitivity of daunorubicin in patients with acute leukemia.
